[1]
“Antitumor Activity of New Methylpyrazolotriazine and Pyrazolobenzotriazine Derivatives Tested on MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines”, Вопр. онкол., vol. 72, no. 3, p. OF-2446, Jul. 2026, doi: 10.37469/0507-3758-2026-72-3-OF-2446.